Opinion|Videos|January 26, 2026
Life on Myeloma Maintenance: Patients Share Their Real Experiences
Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with innovative drug combinations.
Advertisement
Episodes in this series
Maintenance therapy is a long-term phase of multiple myeloma treatment. Patients describe balancing its benefits with the logistical burden of frequent clinic visits. Their experiences highlight that cancer survivorship involves tailoring maintenance to personal tolerance and life goals, learning to "live your life despite the cancer." Open communication with the cancer care team is essential to manage side effects and logistics, making sustained treatment feasible within a thriving life.
Advertisement
Related to this article
Gentle movement during cancer treatment can help maintain strength, mobility and balance. Follow Jennifer Tipton’s simple exercises to keep your body moving.
At three years, 69% of patients treated with Imfinzi and chemotherapy around surgery were alive, compared with 62% of patients treated with chemotherapy alone.
Hannah was 11 when she was diagnosed with acute lymphoblastic leukemia (ALL). Four years, two relapses and a 53-day hospital stay later, she is back in school.
A reflection on shame, vulnerability and transformation, exploring how the past shapes us and how presence can help us let go and heal.
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer.
AJ Wyman shares his daughter’s cancer journey and why parents caring for a child with cancer must make time for their own mental health, too.
A powerful reflection on finding hope, healing and meaning through life’s challenges, inspired by the lessons and beauty found in the sea.
In the phase 3 DESTINY-Lung04 trial, patients with HER2-mutant advanced non-small cell lung cancer treated with Enhertu went a median of 14.3 months without their disease worsening, compared with 8.3 months with immunotherapy plus chemotherapy.
Advertisement
Advertisement
Trending on CURE
1
Enhertu in HER2-Mutant Lung Cancer: The First Year, Side Effects and Sequencing
2
A Gift from the Sea
3
Top 3 Takeaways From WCLC 2026 That Patients Should Know
4
Childhood Leukemia Survivor Shares Her Experience With ALL, Relapse and CAR-T
5